Study of Subcutaneous and Intravenous Velcade in Combination With Dexamethasone in Chinese Subjects With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT02811978 · COMPLETED
Trial details
- NCT number
- NCT02811978
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-27
- Primary completion
- 2018-05-07
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.